Lannett Hits A High After Loss Of Levothyroxine

Company Plans To Launch Several New Products By End Of June

 
• By Akriti Seth
  
Coming_Soon
Lannett’s pipeline has 20 products in development and 17 pending ANDAs • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business